This monograph explains the considerable impact that monoclonal antibodies and molecular probes have had on the diagnosis of tumor types and sub-types. It explains how radiolabelled monoclonal antibodies have also been used as imaging agents to try to improve the oncologist's ability to define residual tumor deposits after combination chemo/radiotherapy. Finally, the childhood malignancies that still have a poor prognosis are presented, and new novel ways of therapy are explained.
- | Author: John T. Kemshead
- | Publisher: Crc Press
- | Publication Date: Oct 29, 2020
- | Number of Pages: 199 pages
- | Language: English
- | Binding: Paperback
- | ISBN-10: 0367451069
- | ISBN-13: 9780367451066